Avalyn Pharma Alternatives & Competitors
12 companies similar to Avalyn Pharma — Revolutionizing respiratory care with every breath
Jazz Pharmaceuticals
Identifying, developing and commercializing meaningful products that address unmet medical...
Dublin, Ireland
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
Cambridge, United States
Track all Avalyn Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
EUSA Pharma
Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recor...
Hemel Hempstead, United K...
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Deciduous Therapeutics
Deciduous is developing a novel class of immune-modulatory therapies designed to promote a...
San Francisco, United Sta...
Portola Pharmaceuticals
South San Francisco, Unit...
GENOME INSIGHT INC.
Cancer whole genome platform company
San Diego, United States
Endeavor BioMedicines
Boldly pursuing development of transformational medicines that may restore hope for patien...
San Diego, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
About Avalyn Pharma
Revolutionizing respiratory care with every breath
Development of inhaled therapies, Drug delivery solutions, Clinical trials
Patients with rare lung diseases, Healthcare providers, Biopharmaceutical investors
Pulmonary Fibrosis Treatment, Respiratory Care, Inhaled Formulations, Interstitial Lung Diseases, Pirfenidone, Nintedanib, Idiopathic Pulmonary Fibrosis, Biopharma Company, Therapeutics Development, Lung Exposure, Systemic Exposure Reduction, Phase 2b MIST Study, Optimized Inhaled Therapies, Severe Respiratory Diseases, Drug Formulation
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Avalyn Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Avalyn Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.